ABSTRACT Background. Prior work has shown that the competitiveness of the market in which hospitals operate is associated with use of surgical procedures. This study examined the association between regional market competition and use of breast reconstruction for women with breast cancer and ductal carcinoma in situ undergoing mastectomy. Methods. Women who underwent mastectomy from 2010 to 2011 recorded in the National Inpatient Sample were selected. The competitive market environment for each hospital in which patients were treated was estimated using the Herfindahl-Hirschman Index. Multivariable models were developed to examine the association between regional market competition and breast reconstruction, with adjustment for other clinical, demographic, and structural variables. Results. Immediate breast reconstruction was performed for 9902 (45%) of 22,011 women. The rate of immediate breast reconstruction was 34.5% at hospitals in non-competitive markets, 49% at hospitals in moderately competitive markets, and 56.4% at hospitals in highly competitive markets (P \ 0.0001). In a multivariable model, women in moderately competitive markets were 24% (risk ratio [RR] 1.24; 95% confidence interval [CI] 1.10-1.41) more likely to undergo immediate breast reconstruction than women in noncompetitive markets, whereas those in competitive markets were 25% (RR 1.25; 95% CI 1.11-1.41) more likely to have reconstruction. Later year of treatment, higher census tract income level, and residence in an urban area were associated with an increased likelihood of reconstruction (P \ 0.05 for all). In contrast, older age, non-white race, and non-commercial insurance were associated with a lower likelihood of reconstruction (P \ 0.05 for all). Conclusion. Patients who undergo mastectomy at hospitals in competitive markets are more likely to undergo immediate breast reconstruction.
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For women undergoing mastectomy, immediate breast reconstruction offers a number of short-and long-term psychological benefits including improved self-esteem and body image and decreased levels of anxiety and depression. [1] [2] [3] [4] Based on these benefits, it is recommended that women should be counseled about the benefits of reconstruction before undergoing mastectomy. 5 These guidelines apply to women with invasive breast cancer undergoing mastectomy as well as to those with ductal carcinoma in situ (DCIS).
Despite the benefits of immediate breast reconstruction, studies have shown that the procedure is consistently underused. [6] [7] [8] Among women with breast cancer who underwent mastectomy, the rate of reconstruction was only 27% in 2005 but rose steeply to 43% by 2014. 6 Access to breast reconstruction remains a challenge, with minority women and those with low socioeconomic status having particularly low rates of reconstruction.
In addition to clinical and demographic factors, there is growing recognition that the contextual environment in which a patient receives care influences the type of care rendered.
9-11 A hospital's underlying financial status as well as the competitive market forces in which hospitals operate are two such factors. [9] [10] [11] [12] Hospitals located in competitive market environments are more likely to offer technologically advanced and specialized treatments, sometimes including interventions that have not demonstrated efficacy. [9] [10] [11] The desire to increase market share is a likely factor in a hospital's decision to offer such treatments.
Because the availability and use of immediate breast reconstruction may be one factor influencing patients' decision on where to undergo mastectomy, we hypothesized that hospitals located in competitive market environments would be more likely to offer immediate breast reconstruction, as women may be more likely to seek out breast cancer surgery at institutions in which reconstructive surgeons are also available. This study aimed to examine the association between regional market competition and the use of breast reconstruction for women with breast cancer or DCIS undergoing mastectomy.
METHODS

Data Sources and Cohort
We used data from the National (Nationwide) Inpatient Sample (NIS) to identify women who underwent mastectomy. The NIS is a discharge database that captures a random sample comprising 20% of hospital discharges in the United States. In 2010, the NIS included data on approximately 8 million hospital stays from 45 states. 13 Data on regional market competition were ascertained from the Hospital Market Structure (HMS) file, which we linked to the NIS. 14, 15 The HMS file includes data describing market competition that are updated every 3 years. Therefore, we used the data from 2009 and excluded the unlinked hospitals.
We selected women 18-90 years of age who underwent a mastectomy for invasive breast cancer or DCIS in 2010 and 2011 (Fig. 1, Table S1 ). Patients who had a secondary malignancy to the breast were excluded from the study.
Competitiveness Measures
We used the Herfindahl-Hirschman Index (HHI) to measure hospital competition. The HHI, a commonly accepted measure of market concentration, [16] [17] [18] is calculated by summing the squared market shares of each hospital competing in the market and multiplying by 10,000. It is generally classified into the following four categories: lower than 100 (highly competitive), 100-1500 (unconcentrated markets, competitive), 1500-2500 (moderately concentrated), and higher than 2500 (highly concentrated markets, noncompetitive). 18 Because few hospitals have an HHI lower than 100, similar to prior work, we classified hospitals with an HHI lower than 1500 as competitive markets. 9 In the HMS file, a market can be defined by an area enclosed by a variable or fixed radius centered on the hospital, by patient flow, or by geopolitical boundaries. Each hospital's market share is calculated as its number of discharges divided by the total number of discharges from all hospitals in the market. As our primary measure of competition, we used the HHI with a variable radius definition that captures 75% of the hospital's discharges (radius 75% HHI).
We performed additional sensitivity analyses using HHI defined by a 90% variable radius (capturing 90% of discharges), a fixed radius (15 miles), patient flow (collection of patients' zip codes that accounts for 75, 90 or 95% of a hospital's discharge), and geopolitical boundaries based on Metropolitan Statistical Areas (MSA), Health Service Areas (HSA), and Core-Based Statistical Areas (CBSA) and counties.
Patient and Hospital Characteristics
Patients were categorized based on receipt of immediate breast reconstructive surgery (flap or implant/tissue expander). The types of mastectomy (radical, simple, skin sparing) and performance of axillary lymph node dissection (ALND) also were noted (Table S1 ). The demographic characteristics analyzed included year (2010-2011), age (\ 40, 40-49, 50-59, 60-69, 70-79, C 80 years), race/ ethnicity (white, black, Hispanic, other/unknown), income status (low, \ $39,000; medium-low, $39,000-$47,999; medium-high, $48,000-$62,999; high, $63,000 ? , unknown), insurance status (Medicare, Medicaid, private, self-pay, other/unknown), and type of admission (urgent, elective, unknown).
Comorbidity was measured using the Elixhauser Comorbidity Index classified as 0, 1, or 2 and higher. The hospitals were characterized by region (Northeast, Midwest, South, West), teaching status (teaching, nonteaching, unknown), bed size (small, medium, large, unknown), and location (rural, urban, unknown).
Statistical Analysis
Frequency distributions of patient and hospital characteristics were compared using Chi square tests based on receipt of immediate breast reconstruction. We used a mixed-effect log-Poisson regression model to evaluate the association between demographic characteristics and immediate breast reconstruction. The model included radius 75% HHI, breast cancer, mastectomy, axillary lymph node dissection, year, age, race/ethnicity, income and insurance status, type of admission, comorbidity, hospital region, bed size, and location. Hospitals were included as a random intercept to account for hospital-level clustering. Patients from hospitals with unknown bed size and location were excluded from the models because of multicollinearity. Similar models were developed to examine the sensitivity for different HHI measures, with adjustment for the same set of demographic variables. All analyses were performed with SAS version 9.4 (SAS Institute Inc, Cary, NC, USA). All statistical tests were two-sided, and a P value lower than 0.05 was considered statistically significant.
RESULTS
Among 22,011 women, immediate breast reconstruction was performed for 9902 women (45%), whereas 12,109 women (55%) did not undergo reconstruction. The rate of immediate reconstruction was 41.8% among women with invasive breast cancer and 64.4% among those with DCIS (P \ 0.0001) ( Table 1) . Performance of immediate breast reconstruction rose from 41.5% in 2010 to 48.2% in 2011 (P \ 0.0001).
In the unadjusted analysis, the rate of immediate breast reconstruction was 34.5% at hospitals in non-competitive markets, 49% at facilities in moderately competitive markets, and 56.4% in highly competitive markets (P \ 0.0001). In a multivariable model, treatment at a hospital in a competitive regional market was associated with an increased likelihood of immediate breast reconstruction (Table 2 ). Women treated in moderately competitive markets were 24% (risk ratio [RR], 1.24; 95% confidence interval [CI], 1.10-1.41) more likely to undergo immediate breast reconstruction than women treated at hospitals in a non-competitive market, whereas those treated in competitive markets were 25% (RR 1.25; 95% CI 1.11-1.41). more likely to have reconstruction.
Women with DCIS were 20% (RR 1.20; 95% CI 1.14-1.26) more likely to undergo immediate reconstruction than those with invasive cancer (Fig. 2) . Later year of treatment, higher census tract income level, and residence in an urban area also were associated with an increased likelihood of immediate reconstruction (P \ 0.05 for all). In contrast, older age, non-white race, and non-commercial insurance were associated with a lower likelihood of immediate breast reconstruction (P \ 0.05 for all).
These findings were robust in a number of sensitivity analyses (Tables S2 and S3 ). When a 90% radius was used to define regional markets, the risk ratio for immediate reconstruction in competitive markets versus non-competitive markets was 1.39 (95% CI 1.23-1.57). Similarly, using a fixed-radius definition of competition, the risk ratio for immediate reconstruction in a competitive market was 1.21 (95% CI 1.06-1.38). In contrast, competition was not significantly associated with immediate breast reconstruction when patient flow was used as a metric for hospital competition. 
DISCUSSION
The data suggest that the regional market structure in which a hospital operates is associated with the likelihood of immediate breast reconstruction for women who undergo mastectomy. Although only one third of women who underwent surgery in non-competitive markets received immediate reconstruction, the rate was higher than 50% at centers operating in more competitive regional markets. The effect of market competition on access to reconstruction was independent of other clinical and demographic characteristics.
The competitive regional market in which a hospital operates appears to be an important influence on the allocation of care. [9] [10] [11] 19, 20 We previously demonstrated that patients undergoing urologic and gynecologic surgery at a hospital in a competitive market were approximately two to five times more likely to undergo a robotically assisted operation than those treated at hospitals in non-competitive markets. Similarly, use of endovascular surgery for aortic aneurysm repair and laparoscopy for colectomy were more common at hospitals in competitive regional markets. 10, 11 Although market competition appears to be associated with the use of procedures and interventions, the relationship between market competition and quality of care has been inconsistent. Whereas one report found that increased market competition was associated with decreased mortality for common medical conditions, 21 other studies have suggested that the influence of hospital competition on quality of care is minimal. 22, 23 Prior studies examining the influence of market competition on hospital services have predominantly explored the use of novel technologies and devices. 9, 11, 19, 24 Hospitals operating in competitive regional markets are more likely to offer technologically advanced treatments that often are of questionable benefit, a phenomenon that coined the term ''medical arms race.'' [24] [25] [26] Provision of these services is likely geared toward marketing with an aim to Based on radius 75% definition of HHI increase market share. In contrast, our data suggest that regional competitive factors also influence the allocation of a treatment that is recommended and considered best practice. In some scenarios, market competition may promote adherence to evidence-based recommendations. 21 Previous studies have found that a variety of clinical and demographic characteristics can influence the use of immediate reconstruction. Older age, black race, marriage, residence in a rural area, and greater medical comorbidity all have been associated with decreased likelihood of immediate breast reconstruction. 7, 8, [27] [28] [29] Medicaid recipients are 66% less likely to undergo breast reconstruction than women with commercial insurance. 27 Hospital and surgeon factors also influence the performance of breast reconstruction. Similarly, Women who undergo surgery by high-volume surgeons and at highvolume hospitals are more likely to undergo breast reconstruction than women treated by low-volume surgeons and at low-volume centers.
8 Patients treated at financially distressed hospitals also are less likely to undergo immediate breast reconstruction. In one analysis women who received care at hospitals classified as under high financial distress were 20% less likely to undergo breast reconstruction than those who received care at hospitals with low or no financial distress. 12 Our findings of an association between market competition and breast reconstruction were independent of other clinical and demographic characteristics.
Although our study benefited from including a large sample of patient and hospitals, we recognize a number of important limitations. First, we relied on the HerfindahlHirschman Index as a surrogate for market competition.
Although the HHI has been widely used as a measure of competition in evaluation of mergers and acquisitions as well as in studies of medical competition, we cannot exclude the possibility that a small number of hospitals were misclassified. We performed a number of sensitivity analyses in which the definition of a market was varied to explore the validity of our findings. Second, we lacked data on patient preferences and attitudes toward breast reconstruction. Third, although we corrected for a variety of clinical and demographic characteristics, there were undoubtedly unmeasured confounders that influenced the decision to perform immediate breast reconstruction.
Finally, although we identified an association between market competition and immediate breast reconstruction, this may have been a surrogate for a variety of other factors that could have influenced the decision to perform reconstruction. For example, differences in the number of available plastic surgeons across different markets could explain a portion of the competition-based disparity that we noted.
Given the disparities in the use of breast reconstruction, a number of initiatives have been taken to raise awareness about reconstructive options. A number of legislative initiatives have been enacted to ensure that women undergoing mastectomy have access to breast reconstruction. The Women's Health and Cancer Rights Act of 1998 requires group health plans to cover mastectomy that include coverage for reconstructive surgery. 30 In 2010, New York State passed legislation mandating that providers discuss reconstruction options with patients undergoing mastectomy. One study found that Adjusted RR (95% Cl) for IBR 31 These data highlight the importance of contextual factors in the performance of immediate breast reconstruction for women undergoing mastectomy. Although competitive market forces are unlikely to change, these findings suggest that a greater understanding of why women receiving care in non-competitive markets are less likely to undergo reconstruction is needed. One plausible explanation is that access to reconstructive surgeons or hospitals that perform reconstruction is limited in non-competitive market regions. A number of studies have shown that the rate of immediate breast reconstruction is correlated with the density of plastic surgeons in a given geographic region. [32] [33] [34] Furthermore, rural regions and areas with a higher percentage of older patients have a lower concentration of plastic surgeons, which may exacerbate racial and socioeconomic disparities in breast reconstruction. 32, 34 Increasing the availability of plastic surgeons, or alternatively, selective referral of patients to other centers may improve the use of reconstruction in this scenario. Alternatively, hospitals and surgeons in non-competitive regions may preferentially prioritize other more profitable procedures when they face no competitive pressure to offer breast reconstructive surgery. In this scenario, programs and policies to promote reconstruction targeted toward patients, providers, and hospitals may help to raise awareness. Similarly, increasing reimbursements for breast reconstruction or linking reimbursement for mastectomy to reconstruction may help to increase access to breast reconstruction. 12 ACKNOWLEDGMENT Dr. 
